Craig Erker

704 total citations
26 papers, 335 citations indexed

About

Craig Erker is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Craig Erker has authored 26 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Craig Erker's work include Glioma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (10 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Craig Erker is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (10 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Craig Erker collaborates with scholars based in Canada, United States and United Kingdom. Craig Erker's co-authors include Sébastien Perreault, Liyun Zhang, Ke Yan, Julie A. Panepinto, Kristin Bingen, Daddy Mata‐Mbemba, Kathryn E. Flynn, Nada Jabado, Benjamin Ellezam and Geneviève Legault and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Craig Erker

22 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Erker Canada 8 171 127 71 58 53 26 335
Magnus Sabel Sweden 10 181 1.1× 67 0.5× 120 1.7× 79 1.4× 15 0.3× 20 394
B Anandh India 9 86 0.5× 48 0.4× 61 0.9× 51 0.9× 25 0.5× 24 306
Tore Stokland Norway 11 93 0.5× 68 0.5× 84 1.2× 155 2.7× 36 0.7× 15 371
Henrik Carstensen Denmark 12 163 1.0× 71 0.6× 24 0.3× 163 2.8× 50 0.9× 15 468
Marianna Horn United States 8 190 1.1× 177 1.4× 73 1.0× 27 0.5× 52 1.0× 10 327
Stephen M. Stowe United States 7 167 1.0× 62 0.5× 53 0.7× 67 1.2× 66 1.2× 12 412
Arthur Wingerter Germany 10 53 0.3× 67 0.5× 121 1.7× 113 1.9× 20 0.4× 26 419
Douglas Ney United States 13 343 2.0× 149 1.2× 59 0.8× 23 0.4× 109 2.1× 46 518
Marie A. Neu Germany 10 43 0.3× 47 0.4× 111 1.6× 140 2.4× 25 0.5× 29 448
Junyang Zhao China 11 41 0.2× 22 0.2× 61 0.9× 50 0.9× 52 1.0× 37 415

Countries citing papers authored by Craig Erker

Since Specialization
Citations

This map shows the geographic impact of Craig Erker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Erker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Erker more than expected).

Fields of papers citing papers by Craig Erker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Erker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Erker. The network helps show where Craig Erker may publish in the future.

Co-authorship network of co-authors of Craig Erker

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Erker. A scholar is included among the top collaborators of Craig Erker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Erker. Craig Erker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macdonald, Ian, Mareen Sarah Kraus, Craig Erker, et al.. (2025). Intra- and interobserver agreement in evaluation of image-defined risk factors on computed tomography in pediatric neuroblastoma. Pediatric Radiology. 55(2). 305–311.
3.
Das, Sunit, Sébastien Perreault, Stephen Yip, et al.. (2023). INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK. Neuro-Oncology. 25(Supplement_5). v164–v164.
4.
Chadda, Karan R., Palma Solano‐Páez, Gail Horan, et al.. (2023). Embryonal tumor with multilayered rosettes: Overview of diagnosis and therapy. Neuro-Oncology Advances. 5(1). vdad052–vdad052. 4 indexed citations
5.
Macdonald, Ian R., et al.. (2023). MR Imaging of Pediatric Neuroblastoma: Is Gadolinium Enhancement Necessary for Evaluation of Image-Defined-Risk Factors?. Canadian Association of Radiologists Journal. 75(2). 404–411. 2 indexed citations
6.
Erker, Craig, Sylvia Cheng, Kathryn McFadden, et al.. (2022). MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation ofBRAFV600E Mutation,BRAFFusion, and Wild-Type Tumors in Patients without Neurofibromatosis-1. American Journal of Neuroradiology. 43(8). 1196–1201. 6 indexed citations
7.
Erker, Craig, et al.. (2022). Massive Saddle Pulmonary Embolism in a Preterm Neonate With Successful Emergent Open Embolectomy. SHILAP Revista de lepidopterología. 1(1). 40–43. 1 indexed citations
8.
Malbari, Fatema, Craig Erker, Pablo Hernáiz Driever, et al.. (2022). OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO). Neuro-Oncology. 24(Supplement_1). i148–i148. 4 indexed citations
9.
McFadden, Kathryn, Bruce Crooks, P. Daniel McNeely, et al.. (2022). Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report. Neuro-Oncology Advances. 4(1). vdac170–vdac170. 2 indexed citations
10.
Ellezam, Benjamin, Alexander G. Weil, Romain Cayrol, et al.. (2022). Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature. Neuro-Oncology Advances. 4(1). vdac174–vdac174. 6 indexed citations
12.
Crooks, Bruce, Simon Walling, Lynette Bowes, et al.. (2021). RARE-01. ASSESSING THE SYMPTOM DIAGNOSTIC INTERVAL FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMOURS. Neuro-Oncology. 23(Supplement_1). i40–i40.
13.
Erker, Craig, Benita Tamrazi, Tina Young Poussaint, et al.. (2020). Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. The Lancet Oncology. 21(6). e317–e329. 74 indexed citations
14.
Erker, Craig, Benita Tamrazi, Tina Young Poussaint, et al.. (2020). IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP. Neuro-Oncology. 22(Supplement_3). iii355–iii355. 1 indexed citations
15.
Perreault, Sébastien, Valérie Larouche, Uri Tabori, et al.. (2019). A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01. BMC Cancer. 19(1). 1250–1250. 109 indexed citations
16.
Erker, Craig, Ke Yan, Liyun Zhang, et al.. (2018). Impact of pediatric cancer on family relationships. Cancer Medicine. 7(5). 1680–1688. 51 indexed citations
17.
Erker, Craig, Anna R. Huppler, Thomas J. Walsh, et al.. (2017). Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 40(7). e446–e449. 7 indexed citations
18.
Erker, Craig, Paul Harker‐Murray, & Julie‐An Talano. (2016). Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Pediatric Clinics of North America. 64(1). 91–109. 9 indexed citations
19.
Erker, Craig, Paul Harker‐Murray, & Michael J. Burke. (2015). Emerging Immunotherapy in Pediatric Lymphoma. Future Oncology. 12(2). 257–270. 2 indexed citations
20.
Hayes, Sidney, et al.. (2013). Phage Lambda P Protein: Trans-Activation, Inhibition Phenotypes and their Suppression. Viruses. 5(2). 619–653. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026